- Wealth
- ₹1,400 Cr
- Company
- Rossari Biotech
About Sunil Srinivasan Chari
Data last updated:
Sunil Srinivasan Chari is a Managing Director at Rossari Biotech Limited (since 2019), Director at Unitop Chemicals Private Limited (since 2021) and Director at Tristar Intermediates Private Limited (since 2021), and holds 8 more current directorships. The companies operate in Chemicals and Materials, Business Services and Chemicals. The 8 current companies with reported revenue have a combined latest revenue of ₹3,482 Cr; the largest is Rossari Biotech Limited at ₹2,084 Cr (FY 2025). Earlier, Sunil Srinivasan Chari was a Director at Ground Screw Private Limited (2023–2025) and Partner at Alpha Alternatives Msar Llp (2021–2024) and 3 more.
Sunil Chari and family are #1,482 among India's richest people (2026), with wealth of ₹1,400 Cr.
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 26 Sep 2019 | 2009 | ₹2,084 Cr (FY 2025) | Active | |
| Director | 26 Aug 2021 | 1980 | ₹774 Cr (FY 2025) | Active | |
| Director | 01 Sep 2021 | 1997 | ₹293 Cr (FY 2026) | Active | |
| Director | 26 Dec 2013 | 2013 | ₹276 Cr (FY 2025) | Active | |
| Director | 25 Nov 2021 | 2021 | ₹32.35 Cr (FY 2025) | Active | |
| Director | 20 Sep 2002 | 1999 | ₹22.46 Cr (FY 2025) | Active | |
| Director | 10 May 2016 | 2016 | ₹12,000 (FY 2025) | Active | |
| Director | 13 Nov 2006 | 2006 | ₹8,171 (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Nov 2023 | 2022 | ₹6.27 Cr (FY 2025) | Active | |
| Partner | 01 Sep 2021 | 2021 | ₹4,486 Cr (FY 2025) | Active | |
| Director | 11 Jun 2005 | 2003 | ₹1.04 Cr (FY 2023) | Active | |
| Director | 22 Feb 2019 | 2019 | Strike Off | ||
| Director | 18 Apr 2017 | 2017 | ₹3,450 (FY 2023) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sunil Srinivasan Chari
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Srinivasan Chari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Srinivasan Chari
Sunil Srinivasan Chari currently holds 11 directorships: Rossari Biotech Limited (Managing Director, since 26 Sep 2019, revenue ₹2,084 Cr (FY 2025)); Unitop Chemicals Private Limited (Director, since 26 Aug 2021, revenue ₹774 Cr (FY 2025)); Tristar Intermediates Private Limited (Director, since 01 Sep 2021, revenue ₹293 Cr (FY 2026)); Buzil Rossari Private Limited (Director, since 26 Dec 2013, revenue ₹276 Cr (FY 2025)); Romakk Chemicals Private Limited (Director, since 25 Nov 2021, revenue ₹32.35 Cr (FY 2025)); and 6 more.
Sunil Srinivasan Chari was first appointed on 31 Jan 1997 as Director at Rossari Biotech (India) Private Limited. The most recent appointment on record is 07 Feb 2025 at Surfactants Association Of India Sai.
The 8 current companies of Sunil Srinivasan Chari that report revenue have a combined latest revenue of ₹3,482 Cr: Rossari Biotech Limited ₹2,084 Cr (FY 2025); Unitop Chemicals Private Limited ₹774 Cr (FY 2025); Tristar Intermediates Private Limited ₹293 Cr (FY 2026); Buzil Rossari Private Limited ₹276 Cr (FY 2025); Romakk Chemicals Private Limited ₹32.35 Cr (FY 2025); and 3 more.
Sunil Srinivasan Chari held 5 earlier board appointments: Ground Screw Private Limited (Director, 07 Nov 2023 to 14 Oct 2025); Alpha Alternatives Msar Llp (Partner, 01 Sep 2021 to 01 Feb 2024); G & J Garment Processors Private Limited (Director, 11 Jun 2005 to 31 Mar 2008); Rossari Speciality Chemicals Private Limited (Director, from 22 Feb 2019); Rossari Hydra Chemicals Private Limited (Director, from 18 Apr 2017).
The current boards of Sunil Srinivasan Chari's companies include Aseem Dhru (Rossari Biotech Limited), Edward Walter Menezes (Rossari Biotech Limited), Esha Padmanabhan Achan (Rossari Biotech Limited), Gurudas Vishwas Aras (Rossari Biotech Limited), Ketan Sablok (Rossari Biotech Limited), Parul Gupta (Rossari Biotech Limited), among others.